Literature DB >> 3987036

Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy.

B Marescau, I A Qureshi, P De Deyn, J Letarte, R Ryba, A Lowenthal.   

Abstract

The concentrations of guanidino compounds were determined in urine, plasma and cerebrospinal fluid of two patients with hyperargininemia during dietary therapy. alpha-Keto-delta-guanidinovaleric acid, N-alpha-acetylarginine, argininic acid and gamma-guanidinobutyric acid were increased in urine. In plasma, these compounds together with creatine, guanidinoacetic acid, arginine and homoarginine were also increased. In cerebrospinal fluid, only arginine, homoarginine and argininic acid were increased. Trace amounts of alpha-keto-delta-guanidinovaleric acid were found in cerebrospinal fluid of the patient treated with only a low-arginine diet. The concentrations of guanidinosuccinic acid are decreased in urine, plasma and cerebrospinal fluid. During a low-arginine diet, together with sodium benzoate therapy, the plasma and cerebrospinal fluid arginine values returned to normal. There was also a normalization of plasma guanidinoacetic acid and a marked decrease in plasma N-alpha-acetylarginine and argininic acid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987036     DOI: 10.1016/0009-8981(85)90120-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  GC-MS determination of guanidinoacetate in urine and plasma.

Authors:  D H Hunneman; F Hanefeld
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

2.  Homocitrullinuria and homoargininuria in hyperargininaemia.

Authors:  T Kato; M Sano; N Mizutani; C Hayakawa
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

3.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

4.  Loss of [3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency.

Authors:  L Ratnakumari; I A Qureshi; R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

5.  Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.

Authors:  Brian Truong; Gabriella Allegri; Xiao-Bo Liu; Kristine E Burke; Xuling Zhu; Stephen D Cederbaum; Johannes Häberle; Paolo G V Martini; Gerald S Lipshutz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

6.  Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency.

Authors:  Lindsay C Burrage; Qin Sun; Sarah H Elsea; Ming-Ming Jiang; Sandesh C S Nagamani; Arthur E Frankel; Everett Stone; Susan E Alters; Dale E Johnson; Scott W Rowlinson; George Georgiou; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

7.  Untargeted Metabolomics-Based Screening Method for Inborn Errors of Metabolism using Semi-Automatic Sample Preparation with an UHPLC- Orbitrap-MS Platform.

Authors:  Ramon Bonte; Michiel Bongaerts; Serwet Demirdas; Janneke G Langendonk; Hidde H Huidekoper; Monique Williams; Willem Onkenhout; Edwin H Jacobs; Henk J Blom; George J G Ruijter
Journal:  Metabolites       Date:  2019-11-26

8.  AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse.

Authors:  E K Lee; C Hu; R Bhargava; R Ponnusamy; H Park; S Novicoff; N Rozengurt; B Marescau; P De Deyn; D Stout; L Schlichting; W W Grody; S D Cederbaum; G S Lipshutz
Journal:  Gene Ther       Date:  2013-02-07       Impact factor: 5.250

9.  Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders.

Authors:  Lindsay C Burrage; Lillian Thistlethwaite; Bridget M Stroup; Qin Sun; Marcus J Miller; Sandesh C S Nagamani; William Craigen; Fernando Scaglia; V Reid Sutton; Brett Graham; Adam D Kennedy; Aleksandar Milosavljevic; Brendan H Lee; Sarah H Elsea
Journal:  Genet Med       Date:  2019-01-23       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.